Welcome to PharmaMedDevice On Demand! This online webcast library is your key to answering the The PharmaMedDevice 2007 Conference Program was the first of its kind to focus on the diverse challenges associated with the convergence of medical devices, pharmaceuticals and biologics. Leading innovators shared their experiences and successes in this fast growing market. Now you can too with these medical device webinars recorded live onsite!
The future of medical devices is now! As the lines between the medical device, pharmaceutical and biologic industries continue to blur, the pace of innovation is accelerating…don’t be left behind! PharmaMedDevice is your source for combination products education.
Presented by: AnneMarie Moseley, CEO, Aggregate Therapeutics
This timely presentation explores the impact of the converging medical device and biologic industries on the development of regenerative medicine products. By assessing the influence of combination product regulations on both biologic and device products, it provides a necessary focus on the timeliness and cost of device-biologic development and engineering. Through the use of specific industry case studies, gain insight into considerations for evaluating investment in convergent regenerative medicine technologies and strategies for minimizing the overall risk profile.
Click here to access this webcast.
Presented by: Raj Bawa, President, BAWA Biotechnology Consulting, LLC Ola Nerbrink, Principal Scientist, Novo Nordisk Alan Minsk, Partner and Leader Food and Drug Practice Team, Arnall Golden Gregory LLP
Get up to date on the recent trends in nanodrug delivery by exploring innovative technologies in evolutionary nanomedicines and medical devices. Understand the impact of advances taking place in the laboratory as they apply to the development of viable commercial products. A specific case study on the use of the nanotechnology as it transforms the pulmonary drug delivery market will provide key insight on the use of these innovative technologies in drugs and devices. Also, receive pertinent updates on how the FDA views nanotechnology products and current FDA research in the nanotechnology area.
Click here to access this webcast.
|
-
The Future of Device-Biologics
-
Bionanotechnology and Drug Delivery
-
What is “PMOA” and How Will Intercenter Consultations and Collaborations Work?
-
Nanomaterials for Medical Devices
-
The FDA Premarket Review Process for Combination Products
-
Personalized Medicine and Genomic Biomarkers
-
How to Address Cross-Labeling Issues and User Fees
-
BioMEMS Technology and Drug Delivery
-
Success Story of Combination Product Approval
-
How to Ensure a Timely and Effective Review
-
The Marketing Application Process for Combination Products
|
